Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Background
The National Cancer Institute (NCI) is issuing this Notice of Funding Opportunity (NOFO) to support the Carcinogen Hazard Assessment Monographs Program (CHAMP). The program aims to critically and systematically evaluate scientific evidence regarding carcinogenic hazards to humans. Identifying potential carcinogens is crucial for advancing cancer research and informing cancer control and prevention efforts. The resulting monographs will serve as essential references that influence health policy and regulation, ultimately contributing to the reduction of the cancer burden.

Grant Details
The tasks under this grant include:
1. Conducting comprehensive reviews of scientific literature related to carcinogenic hazards.
2. Evaluating the strength of evidence regarding the carcinogenicity of various substances.
3. Preparing detailed monographs that summarize findings and provide recommendations based on the evaluations conducted.
4. Collaborating with other researchers and stakeholders in the field of cancer research to ensure a broad perspective in assessments.

Eligibility Requirements
Eligible applicants include institutions, organizations, and individuals with expertise in cancer research, toxicology, epidemiology, or related fields. Preference may be given to those with a proven track record in conducting systematic reviews or meta-analyses related to carcinogenic hazards.

Period of Performance
The period of performance for this grant is expected to begin upon award and continue for a duration determined by the specific project scope, typically spanning several months to years depending on the complexity of the assessments.

Grant Value
The total value of the grant opportunity has not been explicitly stated; however, individual grant awards may vary based on project scope and budget proposals submitted by applicants.